NEOPLASM
Clinical trials for NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new NEOPLASM trials appear
Sign up with your email to follow new studies for NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough cancers: SGT-53 drug trial launches
Disease control TerminatedThis early-stage study tests a new drug called SGT-53, given alone or with chemotherapy, in children and young adults (ages 1-21) with solid tumors that have come back or not responded to treatment. The main goals are to find safe doses and understand side effects. The study is c…
Matched conditions: NEOPLASM
Phase: PHASE1 • Sponsor: SynerGene Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Researchers collect blood to solve mystery of drug side effects
Knowledge-focused ENROLLING_BY_INVITATIONThis study collects blood samples from people already in other NIH clinical trials who are having or are expected to have serious side effects from their drugs. The goal is to measure drug levels in the blood to better understand why side effects happen. Up to 100 participants ag…
Matched conditions: NEOPLASM
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 02, 2026 02:00 UTC